Hematodermic CD4/CD56 neoplasm;Les hématodermies CD4/CD56

Annales de Pathologie

Volumn 24, Issue 3, 2004, Pages 241-255

  Petrella, Tony ^a,b   Wechsler, Janine ^c   Courville, Philippe ^d   De Muret, Anne ^e   Bosq, Jacques ^f   Déchelotte, Pierre ^g   Feuillard, Jean ^h   Durlach, Anne ⁱ   Vergier, Béatrice ^j  

^a Centre de Pathologie   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

^f IGR   (France)

^g UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^h LIMOGES UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL MAISON BLANCHE   (France)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Blastic NK cell lymphoma; CD4; CD56; Plasmacytoid dendritic cell; Skin

Indexed keywords

CD123 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; FLT3 LIGAND; MICROSOMAL AMINOPEPTIDASE;

DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; REVIEW; SKIN BIOPSY; SKIN LYMPHOMA; SURVIVAL TIME;

EID: 4444307405     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(04)93959-4     Document Type: Review

References (65)

1. Petrella T, Dalac S, Maynadie M, Mugneret F, Thomine E, Courville P et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d' Étude des Lymphomes Cutanes (GFELC). Am J Surg Pathol 1999; 23: 137-46.
2. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. WHO Classification. Tumours of Haematopoietic and Lymphoid Tissues. Lyon. Washington.: IARC press, 2001. 214-215.
3. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994; 47: 278-282.
4. Brody JP, Allen S, Schulman P, Sun T, Chan WC, Friedman HD et al. Acute agranular CD4-positive natural killer cell leukemia. Conprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer 1995; 75: 2474-2483.
5. Dummer R, Potoczna N, Huffner AC, Zimmermann DR, Gilardi S, Burg G. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol 1996; 132: 550-553.
6. Wasik MA, Sackstein R, Novick D, Butmarc JR, Zhang Q, Vonderheid EC et al. Cutaneous CD56 + large T-cell lymphoma associated with high serum concentration of IL-2. Human Pathol 1996; 27: 738-744.
7. DiGiuseppe JA, Louje DC, Williams JE, Miller DT, Griffin CA, Mann RB et al. Blastic natural killer leukemia/lymphoma: A clinicapathologic study. Am J Surg Pathol 1997; 21: 1223-1230.
8. Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M et al. CD-56 positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997; 137: 966-971.
9. Bastian BC, Ott G, Müller-Deubert S, Bröcker EB, Müller-Hermelink HK. Primary cutaneous Natural Killer/T-cell lymphoma. Arch Dermatol 1998; 134: 109-111.
10. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadié M, Trimoreau F et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210-3217.
11. Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR et al. 'Agranular CD4 + CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56 + precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-62.
12. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002; 99: 1556-63.
13. Falcao RP, Garcia AB, Marques MG, Simoes BP, Fonseca BA, Rodrigues ML et al. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity. Leuk Res 2002; 26: 803-7.
14. Child FJ, Mitchell TJ, Whittaker SJ, Calonje E, Spittle M, Crocker J et al. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the U.K. Br J Dermatol 2003; 148: 507-15.
15. Momoi A, Toba K, Kawai K, Tsuchiyama J, Suzuki N, Yano T et al. Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. Leuk Res 2002; 26: 693-8.
16. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94: 2401-8.
17. Chang SE, Choi HJ, Huh J, Choi JH, Sung KJ, Moon KC et al. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman. Am J Dermatopathol 2002; 24: 72-5.
18. Penven K, Macro M, Salaun V, Comoz F, Reman O, Leroy D et al. Skin manifestations in CD4+, CD56 + malignancies. Eur J Dermatol 2003; 13: 161-5.
19. Kim SZ, Zollner TM, Schui DK, Chow KU, Sterry W, Kriener S et al. CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X. Leuk Lymphoma 2003; 44: 281-9.
20. Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS, Kim SW. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among koreans [In Process Citation]. Cancer 2000; 89: 2106-16.
21. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCLI Expression in Plasmacytoid Dendritic Cells (DC2) and the Related CD4+ CD56+ Blastic Tumors of Skin. Blood 2003; 6: 6.
22. Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H et al. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen. Am J Hematol 2003; 74: 46-51.
23. Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M et al. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol 2003; 71: 294-8.
24. Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 2002; 99: 4154-9.
25. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J 2000; 1: 53-66.
26. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
27. Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 2003; 40: 175-84.
28. Imamura N, Kusunoki Y, Kawa-Ha K, Yumura K, Hara J, Oda K et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originated from the third lineage of lymphoid cells. British J Haematol 1990; 75: 49-50.
29. Knapp W, Dorken E, Rieber H, Stein H, Gilks WR, Schmidt RE et al. Leucocyte Typing. IV. White Cell Differentition Antigens. Oxford: Oxford University Press 1989; 1: 1093.
30. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR et al. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994; 84: 244-55.
31. Thomas X, Vila L, Campos L, Sabido O, Archimbaud E. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome. Leuk Lymphoma 1995; 19: 295-300.
32. Lee JJ, Chung IJ, Yang DH, Cho SH, Cho D, Ryang DW et al. Clinical significance of CD56 expression in patients with acute myeloid leukemia. Leuk Lymphoma 2002; 43: 1897-9.
33. Vidriales MB, Orfao A, Gonzalez M, Hernandez JM, Lopez-Berges MC, Garcia MA et al. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia 1993; 7: 2026-9.
34. Hsiao CH, Tang JL, Yao M, Tsay W, Wang CH, Chen YC et al. High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t (8;21) in Taiwan. J Formos Med Assoc 2002; 101: 393-8.
35. Ratnam KV, Khor CJ, Su WP. Leukemia cutis. Dermatol Clin 1994; 12: 419-31.
36. Buechner SA, Li CY, Su WP. Leukemia cutis. A histopathologic study of 42 cases. Am J Dermatopathol 1985; 7: 109-19.
37. Lennert K, Remmele W. Karyometrische Untersuchungen an Lymphknotenzellen des Menschen: I: Mitt Germinoblasten, Lymphoblasten und Lymphozyten. Acta Hematol (Basel) 1958; 19: 99-113.
38. Facchetti F, de Wolf-Peeters C, Mason DY, Pulford K, van den Oord JJ, Desmet VJ. Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol 1988; 133: 15-21.
39. Facchetti F, De Wolf-Peeters C, De Vos R, van den Oord JJ, Pulford KA, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol 1980; 20: 588-93.
40. Facchetti F, de Wolf-Peeters C, van den Oord JJ, de Vos R, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchi's lymphadenitis. An immunohistologic study. Am J Clin Pathol 1989; 92: 42-50.
41. Harris NL, Bhan AK. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype. Am J Surg Pathol 1987; 11: 109-13.
42. Facchetti F, De Wolf-Peeters C, van den Oord JJ, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease. J Pathol 1989; 158: 57-65.
43. Facchetti F, Boden G, De Wolf-Peeters C, Vandaele R, Degreef H, Desmet VJ. Plasmacytoid monocytes in Jessner's lymphocytic infiltration of the skin. Am J Dermatopathol 1990; 12: 363-9.
44. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096-102.
45. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000; 165: 4062-8.
46. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997; 185: 1101-11.
47. Facchetti F, de Wolf-Peeters C, van den Oord JJ, Meijer CJ, Pals ST, Desmet VJ. Anti-high endothelial venule monoclonal antibody HECA-452 recognizes plasmacytoid T cells and delineates an "extranodular" compartment in the reactive lymph node. Immunol Lett 1989; 20: 277-81.
48. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000; 96: 878-84.
49. Petrella T, Teitell M, Spiekermann C, Meijer CJLM, Franck F, Enache I. A CD56-negative case of Blastic NK cell Lymphoma (agranular CD4+/CD56 + hematodermic neoplasm). Br J Dermatol 2004; 150: 174-76.
50. Garnache Ottou F, Chaperot L, Ferrand C, Remy-Martin J, DeConninck E, Darodes de Tailly P et al. Expression of the myeloid associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Leukemia (in press).
51. Muller-Hermelink HK, Stein H, Steinmann G, Lennert K. Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol 1983; 7: 849-62.
52. Prasthofer EF, Prchal JT, Grizzle WE, Grossi CE. Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder. Am J Surg Pathol 1985; 9: 380-7.
53. Beiske K, Langholm R, Godal T, Marton PF. T-zone lymphoma with predominance of 'plasmacytoid T-cells' associated with myelomonocytic leukaemia distinct clinicopathological entity. J Pathol 1986; 150: 247-55.
54. Koo CH, Mason DY, Miller R, Ben-Ezra J, Sheibani K, Rappaport H. Additional evidence that "plasmacytoid T-cell lymphoma" associated with chronic myeloproliferative disorders is of macrophage/monocyte origin. Am J Clin Pathol 1990; 93: 822-7.
55. Baddoura FK, Chan WC. Plasmacytoid acute T-cell lymphoma/leukemia. Am J Clin Pathol 1991; 96: 287-8.
56. Baddoura FK, Hanson C, Chan WC. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer 1992; 69: 1457-67.
57. Harris NL, Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization. Am J Surg Pathol 1991; 15: 87-95.
58. Thomas JO, Beiske K, Hann I, Koo C, Mason DY. Immunohistological diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections. J Clin Pathol 1991; 44: 632-5.
59. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P. Involvement of plasmacytoid dendritic cells in human diseases. Hum Immunol 2002; 63: 1201-5.
60. Salio M, Cella M, Vermi W, Facchetti F, Palmowski MJ, Smith CL et al. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol 2003; 33: 1052-62.
61. Vermi W, Bonecchi R, Facchetti F, Bianchi D, Sozzani S, Festa S et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 2003; 200: 255-68.
62. Facchetti F, De Wolf-Peeters C, Van den Oord JJ, Desmet VJ. Plasmacytoid T cells in a case of lymphocytic infiltration of skin. A component of the skin-associated lymphoid tissue? J Pathol 1988; 155: 295-300.
63. Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A et al. What is CD4+ CD56 + malignancy and how should it be treated? Bone Marrow Transplant 2003; 32: 637-46.
64. Kameoka J, Ichinoshasama R, Tanaka M, Miura I, Tomiya Y, Takahashi S et al. A cutaneous agranular CD2- CD4+ CD56+ lymphoma. Report of two cases and review of the literature. Hematology 1998; 110: 478-488.
65. Kojima H, Mukai HY, Shinagawa A, Yoshida C, Kamoshita M, Komeno T et al. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas. Int J Hematol 2000; 72: 477-83.